DNA Wellness Invests Rs 200 Cr for 100 Cervical Cancer Labs
By Rediff Money Desk, Ahmedabad Sep 12, 2024 15:16
DNA Wellness will invest Rs 200 crore to set up over 100 cervical cancer screening labs in India by 2027, using the CERViSure DNA Ploidy Test. The company aims to increase access to this vital screening tool nationwide.
![DNA Wellness Invests Rs 200 Cr for 100 Cervical Cancer Labs](https://im.rediff.com/money/2016/jun/06cancer.jpg)
Ahmedabad, Sep 12 (PTI) City-based DNA Wellness on Thursday said it will invest Rs 200 crore to set up over 100 cervical cancer screening labs across India by 2027.
The company has acquired exclusive rights to conduct the DNA Ploidy Test, a diagnostic tool developed by the British Columbia Cancer Research Agency, Canada, the company said in a statement.
The test, also known as CERViSure, is a quick, accurate, and non-invasive method to detect cervical cancer.
DNA Wellness also announced the launch India's first CERViSure laboratory in Ahmedabad, Gujarat, which will provide easy access to cervical cancer screening facility to people.
"Going forward, DNA wellness will invest Rs 200 crore to set up some 100 dedicated CERViSure laboratories across India, in a phased manner by 2027, to help the DNA Ploidy reach a maximum number of patients," the company said.
"By October 2024, the company will open dedicatedlaboratories in Ahmedabad, Vadodara, Rajkot and Surat," Pathik Bhandari, Co-founder, DNA Wellness, said.
The company will also explore collaboration with hospitals, clinics, and doctors to expand access to the DNA Ploidy Test, aiming to make it available nationwide.
Cervical cancer is a leading cause of cancer-related deaths among women in India, with some 1.3 lakh new cases and 80,000 deaths reported every year, the company said.
DNA Wellness is a leading player in providing advanced DNA profiling technologies in India. It works in the area of detecting genetic instability to improve patient outcomes for screening of diseases.
The company has acquired exclusive rights to conduct the DNA Ploidy Test, a diagnostic tool developed by the British Columbia Cancer Research Agency, Canada, the company said in a statement.
The test, also known as CERViSure, is a quick, accurate, and non-invasive method to detect cervical cancer.
DNA Wellness also announced the launch India's first CERViSure laboratory in Ahmedabad, Gujarat, which will provide easy access to cervical cancer screening facility to people.
"Going forward, DNA wellness will invest Rs 200 crore to set up some 100 dedicated CERViSure laboratories across India, in a phased manner by 2027, to help the DNA Ploidy reach a maximum number of patients," the company said.
"By October 2024, the company will open dedicatedlaboratories in Ahmedabad, Vadodara, Rajkot and Surat," Pathik Bhandari, Co-founder, DNA Wellness, said.
The company will also explore collaboration with hospitals, clinics, and doctors to expand access to the DNA Ploidy Test, aiming to make it available nationwide.
Cervical cancer is a leading cause of cancer-related deaths among women in India, with some 1.3 lakh new cases and 80,000 deaths reported every year, the company said.
DNA Wellness is a leading player in providing advanced DNA profiling technologies in India. It works in the area of detecting genetic instability to improve patient outcomes for screening of diseases.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 13.53 (+ 2.97)
- 43341950
- GTL Infrastructure
- 2.58 ( -1.15)
- 30948547
- Suzlon Energy Ltd.
- 81.64 ( -0.38)
- 27607750
- Rajnish Wellness
- 3.34 ( -3.19)
- 24697355
- Srestha Finvest
- 1.81 (+ 0.56)
- 22617692
MORE NEWS
Areca & Coconut Prices in Mangaluru (September 12)
Get the latest areca and coconut prices in Mangaluru for September 12. Find out the...
![Paytm Shifts...](https://im.rediff.com/80-80/money/2024/feb/12paytm1.jpg)
Paytm Shifts Focus to Profit After Tax: CEO
Paytm CEO Vijay Shekhar Sharma announced the company will prioritize profit after tax...
NBCC to Develop MTNL Land for Rs 1600 Cr Project
NBCC will develop a Rs 1,600 crore housing and commercial project on 14 acres of MTNL...